In this cohort study, researchers identified 6146 patients from 17 registries of the SEER Program who had been diagnosed with a first primary cutaneous Merkel cell carcinoma between 2000 and 2018.
A new analysis found that relapse-free survival is a poor surrogate endpoint for overall survival in adjuvant immunotherapy trials in a variety of cancer types.
However, a post-hoc analysis adds to evidence suggesting that irradiating all metastatic lesions may improve survival in patients receiving immune checkpoint inhibitor monotherapy.
First study to show obesity-related cancer risk is 1.5-fold higher in people with metabolic aberrations as well as obesity, compared with metabolically healthy and normal weight individuals.